Section Arrow
Quote
CELZ.NASDAQ
- Creative Medical Technology Holdings
Quotes are at least 15-min delayed:2025/06/01 08:15 EDT
Last
 2.18
+0.1644 (+8.16%)
Day High 
2.241 
Prev. Close
2.0156 
1-M High
2.2 
Volume 
93.97K 
Bid
2.12
Ask
2.2
Day Low
1.9773 
Open
2.0099 
1-M Low
1.9161 
Market Cap 
5.20M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.01 
20-SMA 2.01 
50-SMA 2.11 
52-W High 6.9 
52-W Low 1.69 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.81/-1.92
Enterprise Value
5.20M
Balance Sheet
Book Value Per Share
3.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.00K
Operating Revenue Per Share
0.03
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed：2025/06/01 08:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells fortherapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.